Insomnia: epidemiology, characteristics, and consequences.
about
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomniaZaleplon for insomniaZopiclone for insomniaZolpidem for insomniaEpidemiologic associations of carpal tunnel syndrome and sleep position: Is there a case for causation?Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomniaSleep disturbance in older ICU patientsMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveLifestyle medicine for depressionCardiovascular and psychiatric morbidity in obstructive sleep apnea (OSA) with insomnia (sleep apnea plus) versus obstructive sleep apnea without insomnia: a case-control study from a Nationally Representative US sample.Sleep disturbances in an arctic population: the Tromsø Study.Visual Display Terminal use in Iranian bank tellers: Effects on job stress and insomnia.Low-dose doxepin for the treatment of insomnia: emerging data.Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohortRaising awareness about sleep disorders.Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implicationsWhy treat insomnia?Insomnia in chronic renal patients on dialysis in Saudi Arabia.Insomnia: definition, prevalence, etiology, and consequencesDiagnosis, prevalence, pathways, consequences & treatment of insomniaEfficacy of a behavioral self-help treatment with or without therapist guidance for co-morbid and primary insomnia--a randomized controlled trial.Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Sleep and daily functioning during androgen deprivation therapy for prostate cancer.The societal costs of insomniaInsomnia medication use and the probability of an accidental event in an older adult population.Insomnia in adults: the impact of earlier cigarette smoking from adolescence to adulthoodPrevalence and polysomnographic correlates of insomnia comorbid with medical disorders.Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication.A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer.Efficacy and tolerability of indiplon in transient insomnia.Discrepancy between subjective symptomatology and objective neuropsychological performance in insomnia.Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities.CHRONIC INSOMNIA AND STRESS SYSTEMTrajectories of cigarette smoking in adulthood predict insomnia among women in late mid-life.Sleep disorders and associated medical comorbidities in active duty military personnel.Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countriesClinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANES
P2860
Q22306021-0B73DF97-8A4B-4A95-A326-12615A408D05Q24200706-5D8C6A7A-187E-435B-B74C-EF776AF50777Q24200717-62292ACF-133A-4410-9DA3-1F7917C7B472Q24200727-1F942A6B-7F9C-4AE3-B127-0D3DFAA0C42DQ24656045-5ADF88A6-E5C0-4E75-973A-4B9AE48C6D37Q24683617-185985B4-C60B-4F19-BA3B-6D4BA268C93FQ27028061-558F5511-D47D-466B-8593-8DCD544EC762Q28083929-E834276B-A41D-4CED-B58E-670CB9484A5BQ28384592-7DD56B77-CB65-4D84-85D9-3FE720FCEA67Q31153185-E27A1C35-E6E1-43AF-B432-8306D39037FAQ33338678-24FB9B69-7E0D-40EC-A689-7DAC68950219Q33457766-78F52202-BCA6-4B5A-88D4-9F90135229FBQ33460649-CD885617-1C52-4162-AB0D-60FDB7A9C8BDQ33635424-78A02888-B38C-4532-A728-D42B9DDE7781Q33668591-04AD7B46-4FE5-4986-9661-931B37467FC9Q33890429-E517E60D-9725-43A5-A794-68DA1B46D065Q33902276-34534528-CE6F-4628-96C0-D6CBCAE76F83Q33968242-2F855859-793C-4F7A-A951-F147C9287ABFQ34006700-F87A7FB8-6A3C-454D-97BC-3AB0AAB6C763Q34105992-3F42D0B8-666A-4D14-A18A-D9822D6C0C6CQ34134585-C1EB5D4B-114C-4AAD-B613-16EEF390DE1FQ34150295-8C15301E-8029-4069-A666-78AC61E47720Q34358480-D4E3D325-BD14-4C2F-8472-FA6AE78833A9Q34472394-E684AADD-2A1E-4A04-A853-6CCC23B5EA12Q34560329-FF518C9A-08E5-4EFF-91E8-C86FE130FFADQ35026469-FA51DEE8-013D-40B0-B12D-6914B8B29A46Q35027697-7CA708B8-F22C-4A33-94E7-EC70D988EFA1Q35059172-D3B17152-EFD8-4A06-AEDA-CB444F73CFA6Q35752989-1A08748A-7A28-405C-BF99-6F01B95333ACQ35846475-C7158F27-8EE6-4F80-983F-8F85F6BBE247Q35846556-6AF7EA31-AB83-483D-8410-EFE57990C65DQ35995317-8D597BB1-A882-4549-A378-C69DDFFDB104Q35995607-E5A6B65E-55EE-407C-AAC3-20E7C60691DFQ36018973-E3ED7343-142C-40BA-BD99-BFF3119157BEQ36041272-AF0D704D-FD69-4CDD-9CCE-89F2205BC156Q36248465-CB352626-0E2B-458F-A122-5CA1895F1B84Q36328496-96F1D186-86DE-4A22-818E-D06F1E41B8B8Q36526438-CE6E5FA9-9302-499A-BF34-1B330105CE8AQ36722184-60218074-395A-4A7C-BD2E-C9AAE461346CQ36927824-40D2EA33-97B9-45FD-9206-A7D817803808
P2860
Insomnia: epidemiology, characteristics, and consequences.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Insomnia: epidemiology, characteristics, and consequences.
@ast
Insomnia: epidemiology, characteristics, and consequences.
@en
type
label
Insomnia: epidemiology, characteristics, and consequences.
@ast
Insomnia: epidemiology, characteristics, and consequences.
@en
prefLabel
Insomnia: epidemiology, characteristics, and consequences.
@ast
Insomnia: epidemiology, characteristics, and consequences.
@en
P1433
P1476
Insomnia: epidemiology, characteristics, and consequences.
@en
P2093
Thomas Roth
Timothy Roehrs
P356
10.1016/S1098-3597(03)90031-7
P577
2003-01-01T00:00:00Z